| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217701 Intracellular calcium concentration increase inhibitors |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366186C Retinoid antagonists and use thereof |
| 05/10/2007 | WO2007053807A2 Calcitriol for treating intraocular diseases associated with angiogenesis |
| 05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
| 05/10/2007 | WO2007011873A3 Method for treating intraocular neovascular diseases |
| 05/10/2007 | WO2006105313A3 Compositions of and methods of using oversulfated glycosaminoglycans |
| 05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 05/10/2007 | US20070105908 Thiazolimine compound and oxazolimine compound |
| 05/10/2007 | US20070105903 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/09/2007 | EP1783215A1 Angiostatin and method of use for inhibition of angiogenesis |
| 05/09/2007 | EP1782801A1 Eyewash liquid for dry eye therapy |
| 05/09/2007 | EP1781300A1 Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1487469A4 Co-beadlet of dha and rosemary and methods of use |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1163274B9 Process for cross-linking hyaluronic acid to polymers |
| 05/09/2007 | EP1126855B1 Use of fused pyrrolocarbazoles for preventing/treating damage to sensory hair cells and cochlear neurons |
| 05/09/2007 | CN1960725A Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis |
| 05/09/2007 | CN1959469A Method for forming contact lenses comprising therapeutic agents |
| 05/09/2007 | CN1958065A Pidotimod capsule, and preparation |
| 05/09/2007 | CN1958014A Desert cistanche pills for improving acuity of sight |
| 05/09/2007 | CN1958000A Method for processing rhizoma coptidis |
| 05/09/2007 | CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314452C Ocular in-situ gel preparation with proper phase conversion temperature |
| 05/08/2007 | US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 05/08/2007 | US7214687 Quinuclidine derivatives and medicinal compositions containing the same |
| 05/08/2007 | US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214672 Preventives/remedies for inflammatory airway diseases |
| 05/08/2007 | US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 05/03/2007 | WO2007050720A1 Loteprednol etabonate against vascular dysfunction in the eye |
| 05/03/2007 | WO2007050615A1 Novel compounds and their use related to compositions for treating glaucoma and/or ocular hypertension |
| 05/03/2007 | WO2007049472A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 05/03/2007 | WO2007048523A1 Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate |
| 05/03/2007 | WO2007048413A1 IMPLANTABLE BIOCOMPATIBLE IMMtTNOISOLATORY VEHICLE FOR DELIVERY OF GDNF |
| 05/03/2007 | WO2007028821A3 Treatment of autoimmune diseases |
| 05/03/2007 | WO2007027761A3 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 05/03/2007 | WO2007019427A3 Methods and compositions for preserving the viability of photoreceptor cells |
| 05/03/2007 | WO2006024770A8 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099990 N-(3-(p-Isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide or a salt thereof; cerebrovascular disorders |
| 05/03/2007 | US20070099953 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099271 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 05/03/2007 | US20070098760 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 05/03/2007 | US20070098692 Materials and methods for treating ocular-related disorders |
| 05/03/2007 | US20070098677 Ophthalmic compositions containing galactomannan polymers and borate |
| 05/03/2007 | CA2627543A1 Implantable biocompatible immttnoisolatory vehicle for delivery of gdnf |
| 05/03/2007 | CA2627215A1 Ophthalmic pharmaceutical compositions comprising amino acids and sodium hyaluronate |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778619A2 T type calcium channel inhibitors |
| 05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 05/02/2007 | EP1778244A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 05/02/2007 | EP1778239A1 Adenosine a3 receptor agonists for the treatment of dry eye disorders including sjogren's syndrome |
| 05/02/2007 | EP1778207A2 Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders |
| 05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1121115B1 Pufa supplements |
| 05/02/2007 | CN1956981A Agent for treating keratoconjunctival trouble |
| 05/02/2007 | CN1956737A Ophthalmic thickening agent |
| 05/02/2007 | CN1954855A Eye preparation containing sodium hyaluronate for treating fundus macular degeneration and its preparation method |
| 05/02/2007 | CN1954824A Traditional Chinese medicine eye preparation and its preparation method and quality control method |
| 05/02/2007 | CN1954823A Medical composite for eye and its preparation method and quality control method |
| 05/02/2007 | CN1313469C Novel derivative of flavone c-glycoside and composition containing the same |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313463C Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313447C 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| 05/02/2007 | CN1313155C Topical composition comprising a cyclofructan, a carrier and a drug |
| 05/02/2007 | CN1313147C Treatment of inner ear hair cells |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313091C Vitamin C composition |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211387 DNA molecule encoding a variant paraoxonase and uses thereof |
| 05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | CA2392917C Pin1 as a marker for abnormal cell growth |
| 05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 04/26/2007 | WO2007047626A1 Combination treatment with anecortave acetate and bevacizumab or ranibizumab for pathologic ocular angiogenesis |
| 04/26/2007 | WO2007047425A1 Resorbable cornea button |
| 04/26/2007 | WO2007047334A1 Prevention and treatment of drug-associated ocular side effects with a cyclosporin |